|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Costa RLB and Gradishar WJ:
Triple-negative breast cancer: Current practice and future
directions. J Oncol Pract. 13:301–303. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bauer KR, Brown M, Cress RD, Parise CA and
Caggiano V: Descriptive analysis of estrogen receptor
(ER)-negative, progesterone receptor (PR)-negative, and
HER2-negative invasive breast cancer, the so-called triple-negative
phenotype: A population-based study from the California cancer
registry. Cancer. 109:1721–1728. 2007.PubMed/NCBI View Article : Google Scholar
|
|
4
|
de Foucher T, Roussel H, Hivelin M, Rossi
L, Cornou C, Bats AS, Deloménie M, Lécuru F and Ngô C: Atypical
distant metastasis of breast malignant phyllodes tumors: A case
report and literature review. Case Rep Obstet Gynecol.
2017(8963013)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sutter SA, Slinker A, Balumuka DD and
Mitchell KB: Surgical management of breast cancer in africa: A
continent-wide review of intervention practices, barriers to care,
and adjuvant therapy. J Glob Oncol. 3:162–168. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Huszno J and Grzybowska E: TP53 mutations
and SNPs as prognostic and predictive factors in patients with
breast cancer. Oncol Lett. 16:34–40. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Langerød A, Zhao H, Borgan Ø, Nesland JM,
Bukholm IR, Ikdahl T, Kåresen R, Børresen-Dale AL and Jeffrey SS:
TP53 mutation status and gene expression profiles are powerful
prognostic markers of breast cancer. Breast Cancer Res.
9(R30)2007.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Gratenstein K, Heggestad AD, Fortun J,
Notterpek L, Pestov DG and Fletcher BS: The WD-repeat protein
GRWD1: Potential roles in myeloid differentiation and ribosome
biogenesis. Genomics. 85:762–773. 2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Fujiyama H, Tsuji T, Hironaka K, Yoshida
K, Sugimoto N and Fujita M: GRWD1 directly interacts with p53 and
negatively regulates p53 transcriptional activity. J Biochem.
167:15–24. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Deng X, Li S, Kong F, Ruan H, Xu X, Zhang
X, Wu Z, Zhang L, Xu Y, Yuan H, et al: Long noncoding RNA PiHL
regulates p53 protein stability through GRWD1/RPL11/MDM2 axis in
colorectal cancer. Theranostics. l10:265–280. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang Q, Ren H, Xu Y, Jiang J, Wudu M, Liu
Z, Su H, Jiang X, Zhang Y, Zhang B and Qiu X: GRWD1 promotes cell
proliferation and migration in non-small cell lung cancer by
activating the notch pathway. Exp Cell Res.
387(111806)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Atwal D, Ramos JM and Makhoul I: Late
breast cancer recurrence with bone marrow metastases and acute
pulmonary hypertension. Proc (Bayl Univ Med Cent). 31:213–215.
2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
McAllister SD, Murase R, Christian RT, Lau
D, Zielinski AJ, Allison J, Almanza C, Pakdel A, Lee J, Limbad C,
et al: Pathways mediating the effects of cannabidiol on the
reduction of breast cancer cell proliferation, invasion, and
metastasis. Breast Cancer Res Treat. 129:37–47. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Takafuji T, Kayama K, Sugimoto N and
Fujita M: GRWD1, a new player among oncogenesis-related
ribosomal/nucleolar proteins. Cell Cycle. 16:1397–1403.
2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kayama K, Watanabe S, Takafuji T, Tsuji T,
Hironaka K, Matsumoto M, Nakayama KI, Enari M, Kohno T, Shiraishi
K, et al: GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway
and promotes tumorigenesis. EMBO Rep. 18:123–137. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Pan Y, Yuan Y, Liu G and Wei Y: P53 and
Ki-67 as prognostic markers in triple-negative breast cancer
patients. PLoS One. 12(e0172324)2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xu L, Wang S, Zhao Z and Wang K:
Expression and prognosis of VEGF and P53 in tissues and serum of
patients with triple negative breast cancer. Journal of Nanjing
Medical University (Natural Sciences). 41:118–121. 2021.(In
Chinese).
|
|
19
|
Aigner K, Dampier B, Descovich L, Mikula
M, Sultan A, Schreiber M, Mikulits W, Brabletz T, Strand D, Obrist
P, et al: The transcription factor ZEB1 (deltaEF1) promotes tumour
cell dedifferentiation by repressing master regulators of
epithelial polarity. Oncogene. 26:6979–6988. 2007.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Choi BD, Jeong SJ, Wang G, Park JJ, Lim
DS, Kim BH, Cho YI, Kim CS and Jeong MJ: Secretory leukocyte
protease inhibitor is associated with MMP-2 and MMP-9 to promote
migration and invasion in SNU638 gastric cancer cells. Int J Mol
Med. 28:527–534. 2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Burlaka AP, Ganusevich II, Gafurov MR,
Lukin SM and Sidorik EP: Stomach cancer: Interconnection between
the redox state, activity of MMP-2, MMP-9 and stage of tumor
growth. Cancer Microenviron. 9:27–32. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yuan X, Wu H, Han N, Xu H, Chu Q, Yu S,
Chen Y and Wu K: Notch signaling and EMT in non-small cell lung
cancer: Biological significance and therapeutic application. J
Hematol Oncol. 7(87)2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Giuli MV, Giuliani E, Screpanti I,
Bellavia D and Checquolo S: Notch signaling activation as a
hallmark for triple-negative breast cancer subtype. J Oncol.
2019(8707053)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chiang MY, Radojcic V and Maillard I:
Oncogenic notch signaling in t-cell and B-cell lymphoproliferative
disorders. Curr Opin Hematol. 23:362–370. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Allen TD, Rodriguez EM, Jones KD and
Bishop JM: Activated notch1 induces lung adenomas in mice and
cooperates with myc in the generation of lung adenocarcinoma.
Cancer Res. 71:6010–6018. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Licciulli S, Avila JL, Hanlon L, Troutman
S, Cesaroni M, Kota S, Keith B, Simon MC, Puré E, Radtke F, et al:
Notch1 is required for Kras-induced lung adenocarcinoma and
controls tumor cell survival via p53. Cancer Res. 73:5974–5984.
2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kar R, Jha NK, Jha SK, Sharma A, Dholpuria
S, Asthana N, Chaurasiya K, Singh VK, Burgee S and Nand P: A
‘NOTCH’ deeper into the epithelial-to-mesenchymal transition (EMT)
program in breast cancer. Genes. 10(961)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kong P, Chen L, Yu M, Tao J, Liu J, Wang
Y, Pan H, Zhou W and Wang S: miR-3178 inhibits cell proliferation
and metastasis by targeting Notch1 in triple-negative breast
cancer. Cell Death Dis. 9(1059)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Xiao YS, Zeng D, Liang YK, Wu Y, Li MF, Qi
YZ, Wei XL, Huang WH, Chen M and Zhang GJ: Major vault protein is a
direct target of notch1 signaling and contributes to
chemoresistance in triple-negative breast cancer cells. Cancer
Lett. 440-441:156–167. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sun D, Lei W, Hou X, Li H and Ni W: PUF60
accelerates the progression of breast cancer through downregulation
of PTEN expression. Cancer Manag Res. 11:821–830. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lin Y, Zhang J, Li Y, Guo W, Chen L, Chen
M, Chen X, Zhang W, Jin X, Jiang M, et al: CTPS1 promotes malignant
progression of triple-negative breast cancer with transcriptional
activation by YBX1. J Transl Med. 20(17)2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Eskiler GG, Sahin E, Ozkan AD, Kaya OT and
Kaleli S: Curcumin induces DNA damage by mediating homologous
recombination mechanism in triple negative breast cancer. Nutr
Cancer. 72:1057–1066. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Iso T, Kedes L and Hamamori Y: HES and
HERP families: Multiple effectors of the notch signaling pathway. J
Cell Physiol. 194:237–255. 2003.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Stifani S, Blaumueller CM, Redhead NJ,
Hill RE and Artavanis-Tsakonas S: Human homologs of a drosophila
enhancer of split gene product define a novel family of nuclear
proteins. Nat Genet. 2:119–127. 1992.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Maier MM and Gessler M: Comparative
analysis of the human and mouse Hey1 promoter: Hey genes are new
notch target genes. Biochem Biophys Res Commun. 275:652–660.
2000.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ronchini C and Capobianco AJ: Induction of
cyclin D1 transcription and CDK2 activity by Notch(ic): Implication
for cell cycle disruption in transformation by Notch(ic). Mol Cell
Biol. 21:5925–5934. 2001.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Oswald F, Liptay S, Adler G and Schmid RM:
NF-kappaB2 is a putative target gene of activated Notch-1 via
RBP-Jkappa. Mol Cell Biol. 18:2077–2088. 1998.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Weng AP, Millholland JM, Yashiro-Ohtani Y,
Arcangeli ML, Lau A, Wai C, Bianco CD, Rodriguez CG, Sai H, Tobias
J, et al: c-Myc is an important direct target of Notch1 in T-cell
acute lymphoblastic leukemia/lymphoma. Genes Dev. 20:2096–2109.
2006.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Choi JW, Pampeno C, Vukmanovic S and
Meruelo D: Characterization of the transcriptional expression of
notch-1 signaling pathway members, Deltex and HES-1, in developing
mouse thymocytes. Dev Comp Immunol. 26:575–588. 2002.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kobayashi T, Mizuno H, Imayoshi I,
Furusawa C, Shirahige K and Kageyama R: The cyclic gene Hes1
contributes to diverse differentiation responses of embryonic stem
cells. Genes Dev. 23:1870–1875. 2009.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Suh JH, Lee HW, Lee JW and Kim JB: Hes1
stimulates transcriptional activity of Runx2 by increasing protein
stabilization during osteoblast differentiation. Biochem Biophys
Res Commun. 367:97–102. 2008.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Himes AD and Raetzman LT: Premature
differentiation and aberrant movement of pituitary cells lacking
both Hes1 and Prop1. Dev Biol. 325:151–161. 2009.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Lu L, Liu S, Dong Q and Xin Y: Salidroside
suppresses the metastasis of hepatocellular carcinoma cells by
inhibiting the activation of the notch1 signaling pathway. Mol Med
Rep. 19:4964–4972. 2019.PubMed/NCBI View Article : Google Scholar
|
